Observational Study
Copyright ©The Author(s) 2017.
World J Diabetes. May 15, 2017; 8(5): 222-229
Published online May 15, 2017. doi: 10.4239/wjd.v8.i5.222
Table 1 Kidney Disease Improving Global Guidelines-2012 Prognostic Categories of Chronic Kidney Disease according to estimated glomerular filtration rate and albuminuria (adapted from the Reference 2)
Albuminuria categories [albumin/creatinine (mg/mmol)]
A1A2A3
< 33-30≥ 30
Normal to mildly increasedModerately increasedSeverely increased
eGFR categories (mL/min per 1.73 m2)G1, ≥ 90Low riskModerately increased riskHigh risk
Normal/high
G2, 60-90Low riskModerately increased riskHigh risk
Mildly decreased
G3a, 45-59Moderately increased riskHigh riskVery high risk
Mildly to moderately decreased
G3b, 30-44High riskVery high riskVery high risk
Moderately to severely decreased
G4, 15-29Very high riskVery high riskVery high risk
Severely decreased
G5, < 15Very high riskVery high riskVery high risk
Kidney failure
Table 2 Clinical characteristics of the study subjects across the Kidney Disease Improving Global Guidelines-2012 categories of albuminuria
Category of Albuminuria
A1A2A3
N (M/F)372 (212/198)166 (87/79)72 (38/34)
Age (yr)63 (19-88)68 (18-88)60a,b (29-85)
Glucose (mmol/L)9.0 (8.8-9.3)9.4 (8.9-10.0)7.4a,b (5.7-8.9)
HbA1c (%)7.4 (7.3-7.6)7.5 (7.3-7.7)7.8 (7.4-8.5)
HbA1c (mmol/mol)59 (57-61)59 (57-61)62 (58-71)
e-SCr (μmol/L)69b,d (66-72)75a,d (72-77)100a,b (88-137)
cJ-SCr (μmol/mol)70b,d (67-72)77a,d (72-81)108a,b (87-140)
e-SCr-eGFR (mL/min per 1.73 m2)91b,d (88-93)85a,d (80-88)60a,b (39-77)
cJ-SCr-eGFR (mL/min per 1.73 m2)90b,d (87-92)83a,d (76-86)55a,b (39-73)
Table 3 Reclassification of the estimated glomerular filtration rate based chronic kidney disease stage according to enzymatic and compensated Jaffé creatinine values
e-SCr-eGFR-based CKD stage
123A3B4Total
cJ-SCr-eGFR-based CKD stage1272152010101277 (42.7)
22532061220101233 (36)
3a01233541010177 (11.9)
3b0101532811234 (5.2)
40101011326127 (4.2)
Total297 (45.8)234 (36.1)61 (9.4)29 (4.5)27 (4.2)648